Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Detalles Bibliográficos
Autores principales: Choughule, A, Sharma, R, Trivedi, V, Thavamani, A, Noronha, V, Joshi, A, Desai, S, Chandrani, P, Sundaram, P, Utture, S, Jambhekar, N, Gupta, S, Aich, J, Prabhash, K, Dutt, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260019/
https://www.ncbi.nlm.nih.gov/pubmed/25117816
http://dx.doi.org/10.1038/bjc.2014.401

Ejemplares similares

Ejemplares similares